| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/28/2001 | WO2000073452A3 Compositions and methods for the treatment of immune related diseases |
| 06/28/2001 | WO2000073446A3 Adipocyte complement related protein homolog zacrp6 |
| 06/28/2001 | WO2000073344A3 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules |
| 06/28/2001 | WO2000073333A3 Ligand for cd7, and methods for use thereof |
| 06/28/2001 | WO2000073331A3 Use of exendins and agonists thereof for the treatment of gestational diabetes mellitus |
| 06/28/2001 | WO2000072855A3 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 06/28/2001 | WO2000071149A3 Therapeutic uses of bpi protein products in humans with otitis media with effusion |
| 06/28/2001 | WO2000070049A3 Extracellular signaling molecules |
| 06/28/2001 | WO2000070047A3 Full-length molecules expressed in human tissues |
| 06/28/2001 | WO2000068247A3 Serine proteases |
| 06/28/2001 | WO2000067773A3 Combinations of immunosupressive agents for the treatment or prevention of graft rejections |
| 06/28/2001 | WO2000066731A3 Recombinant laminin 5 |
| 06/28/2001 | WO2000066708A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/28/2001 | WO2000066116A3 Stable solid pharmaceutical compositions containing enalapril maleate |
| 06/28/2001 | WO2000063236A3 Adhesion modulatory peptides and methods for use |
| 06/28/2001 | WO2000061753A3 Compositions and methods for the treatment and diagnosis of breast cancer |
| 06/28/2001 | WO2000061613A3 Channel forming toxins as antiviral agents |
| 06/28/2001 | WO2000061180A3 Products and methods for treating ptp lar related diseases |
| 06/28/2001 | WO2000060359A3 Interactions of ku polypeptides |
| 06/28/2001 | WO2000055321A3 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 06/28/2001 | WO2000055194A3 Tuberculosis antigens and methods of use therefor |
| 06/28/2001 | WO2000044774A3 Inhibition of stat3 signal transduction for human cancer therapy |
| 06/28/2001 | WO1999064461A9 Monoclonal antibodies, cross-reactive antibodies and method for producing the same |
| 06/28/2001 | WO1999063937A9 Multivalent macrolide antibiotics |
| 06/28/2001 | WO1999046575A3 Peptides containing a cholesterol recognition sequence and their uses |
| 06/28/2001 | WO1997046686A3 Tumor necrosis factor-related polypeptide |
| 06/28/2001 | US20010005747 Bispecific molecules comprising a target cell specific ligand and an effector cell specific antibody or functional antibody fragment |
| 06/28/2001 | US20010005717 Gene transfer complexes of a polyethyleneimine having a hydrophilic polymer such as polyoxyethylene glycol coupled thereto, and a nucleic acid; use in gene therapy |
| 06/28/2001 | US20010005714 Amphipathic molecules as cholesterol and other lipid uptake inhibitors |
| 06/28/2001 | US20010005713 Use of heat shock proteins to deliver moieties into cells |
| 06/28/2001 | US20010005712 Parenterally administering Product R, a peptide-nucleic acid preparation, in combination with one or more antiviral agents useful for treating AIDS or HIV infections including HIV protease inhibitors and nucleosides |
| 06/28/2001 | US20010005579 Providing an amount of beta-alanine and L-histidine to blood or blood plasma effective to increase beta-alanylhistidine dipeptide synthesis in a tissue, exposing tissue to blood or plasma to increase accumulation of dipeptide in the tissue |
| 06/28/2001 | US20010005506 Producing a disease-specific immunogenic cell by isolating CD34 negative hematopoietic stem cells, incubating in culture medium with colony stimulating factor, and interleukin-4 to develop into programmable antigen presenting cells (pAPC's) |
| 06/28/2001 | US20010005505 Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer |
| 06/28/2001 | US20010005501 A pharmaceutical composition comprising a mixture of hyaluronic acid and liposomes, and is free of superoxide dismutase; improves stability of liposomes; gene therapy; cyclosporin A delivery |
| 06/28/2001 | DE19962583A1 New antibodies specific for plasma cells, useful for treatment and diagnosis of autoimmune diseases and plasma cell tumors |
| 06/28/2001 | DE19962010A1 Antiviral combination based on dihydropyrimidine derivatives and non-dihydropyrimidine HBV antiviral agents, are useful for treatment of HBV infections |
| 06/28/2001 | DE19961733A1 Oil-in-water emulsion comprising cyclosporin, is useful for treating neurological disease and as a neuroprotectant, comprises triglyceride, natural emulsifier and a hypertonicity agent |
| 06/28/2001 | DE19958121A1 Tyrosin- und tryptophanhaltige Peptide als Antioxidantien Tyrosine and tryptophan-containing peptides as antioxidants |
| 06/28/2001 | DE19957065A1 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 06/28/2001 | DE10027954A1 Humanes Procalcitonin, dessen Herstellung und Verwendung Human procalcitonin, its preparation and use |
| 06/28/2001 | CA2396677A1 Inhibition of cellular proteases |
| 06/28/2001 | CA2395714A1 Novel tachykinin-like polypeptides and use thereof |
| 06/28/2001 | CA2395576A1 Replication incompetent herpes viruses for use in gene therapy |
| 06/28/2001 | CA2395525A1 Transferrin polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2395416A1 P2y12 receptor |
| 06/28/2001 | CA2395406A1 Method for treating inflammation |
| 06/28/2001 | CA2395369A1 Cytokine zcyto18 |
| 06/28/2001 | CA2395286A1 Aspartyl proteases |
| 06/28/2001 | CA2395212A1 Polynucleotides and polypeptides encoded thereby |
| 06/28/2001 | CA2395197A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 06/28/2001 | CA2395136A1 Angiogenesis and vascular permeability modulators and inhibitors |
| 06/28/2001 | CA2395102A1 Human kinases |
| 06/28/2001 | CA2395093A1 Mammalian protein phosphatases |
| 06/28/2001 | CA2395007A1 Transporters and ion channels |
| 06/28/2001 | CA2394997A1 Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections |
| 06/28/2001 | CA2394877A1 Compounds and use thereof to modify transport across cell membranes |
| 06/28/2001 | CA2394789A1 Proteases |
| 06/28/2001 | CA2394757A1 Novel gene and use thereof |
| 06/28/2001 | CA2394589A1 Modulation of pax-2 for controlled apoptosis or survival of cells |
| 06/28/2001 | CA2394520A1 Sensitive substance encapsulation |
| 06/28/2001 | CA2394049A1 Vesicle trafficking proteins |
| 06/28/2001 | CA2394015A1 Tweak receptor |
| 06/28/2001 | CA2393855A1 Homologues of human heparanase and splice variants thereof |
| 06/28/2001 | CA2393646A1 Survivin promotion of angiogenesis |
| 06/28/2001 | CA2393586A1 Use of heat shock proteins |
| 06/28/2001 | CA2393018A1 A stable immunogenic composition for frozen storage |
| 06/28/2001 | CA2392787A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2391594A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2391374A1 Il-17 homologous polypeptides and therapeutic uses thereof |
| 06/28/2001 | CA2390691A1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 06/28/2001 | CA2384326A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs |
| 06/27/2001 | EP1111388A1 Interaction between CD14 and HBV components |
| 06/27/2001 | EP1111066A1 Recombinant human sm-11044-binding receptor protein having activity of binding to ligand and utilization thereof |
| 06/27/2001 | EP1111055A1 Plant enzymes with phospholipid hydroperoxide glutathione peroxidase activity, their analogues and their use |
| 06/27/2001 | EP1111054A1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them |
| 06/27/2001 | EP1111053A2 Peptide fragment of the respiratory syncytial virus G protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 06/27/2001 | EP1111050A2 Human procalcitonin, its production and use |
| 06/27/2001 | EP1111048A2 Neutral amino acid transporter and gene thereof |
| 06/27/2001 | EP1111046A1 Novel protein and process for producing the same |
| 06/27/2001 | EP1111045A2 Apoptin-associating protein |
| 06/27/2001 | EP1111041A1 Systemic carnitine deficiency gene and utilization thereof |
| 06/27/2001 | EP1110969A1 Interleukin 18-binding protein |
| 06/27/2001 | EP1110968A1 Thrombininhibitors as anticoagulant agents |
| 06/27/2001 | EP1110556A1 Preventives/remedies for multiple organ failure |
| 06/27/2001 | EP1109928A1 Enzymatic oxidative deamination process |
| 06/27/2001 | EP1109921A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof |
| 06/27/2001 | EP1109919A2 Rationally designed heparinases derived from heparinase i and ii |
| 06/27/2001 | EP1109918A2 Polypeptides, polynucleotides and uses thereof |
| 06/27/2001 | EP1109917A2 Human transferase proteins |
| 06/27/2001 | EP1109914A2 Inhibition of smooth muscle cell migration by heme oxygenase 1 |
| 06/27/2001 | EP1109911A2 Staphylococcus aureus genes and polypeptides |
| 06/27/2001 | EP1109909A2 Grf analogs with increased biological potency |
| 06/27/2001 | EP1109908A2 Leptin induced genes |
| 06/27/2001 | EP1109907A1 Human cell junction pdz protein |
| 06/27/2001 | EP1109906A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
| 06/27/2001 | EP1109905A1 Genes encoding for the human and murine death inducer-obliterator-1 |
| 06/27/2001 | EP1109903A2 Human rna-associated proteins |
| 06/27/2001 | EP1109901A2 GABA B RECEPTOR SUBTYPES GABA B-R1c AND GABA B-R2 AND HETERODIMERS THEREOF |
| 06/27/2001 | EP1109900A1 Angiocidin: a cys-ser-val-thr-cys-gly specific tumor cell adhesion receptor |